NANO PPC

Dosage form: cream
Ingredients: VANILLYL BUTYL ETHER 2.50mg in 250mL, CAFFEINE 1.25mg in 250mL
Labeler: YBK Investment, INC
NDC code: 60709-107

Medically reviewed by Drugs.com. Last updated on Dec 1, 2023.

NANO-PPC 250mL

NANO-PPC

massage and slimming cream

Active ingredients: Caffeine (0.5%)

Reduce the appearance of cellulite

Inactive ingredients:

Water, Mineral oil, Propylene glycol, Glycerin, Glyceryl stearate, Stearic acid, isopropyl myristate, Petrolatum, Polysorbate 60, Cetyl alcohol, Olea europaea (olive) fruit oil, Sorbitan sesquioleate, Dimethicone, Potassium acetyl phosphate, Methylparaben, Sodium lauryl glutamate, Carbomer, Triethanolamine, Imidazolidinyl urea, Propylparaben, Butylated hydroxytoluene, Disodium EDTA, Glycine soja (soybean) oil, Hydrogenated lecithin, Carnitine

Active ingredients: Caffeine (0.5%)

Keep out of reach of children

Direction for use

Apply suitable amount of the cream on target area.

Gently massage for 3 minutes until it is absorbed. Cleanse with tissue or water.

Cautions

For external use only, not to be swallowed. In case of accidental ingestion, seek professional assistance. Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water. Do not apply directly to wound or open cut. Store at room temperature

Reduce the appearance of cellulite

Inactive ingredients:

massage skin

reduce the appearance of cellulite

Stop use and consult a doctor if rash or irritation develops and lasts.

Cautions

NANO PPC
caffeine cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:60709-107
Route of Administration	TOPICAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
VANILLYL BUTYL ETHER (VANILLYL BUTYL ETHER)	VANILLYL BUTYL ETHER	2.50 mg in 250 mL
CAFFEINE (CAFFEINE)	CAFFEINE	1.25 mg in 250 mL

Inactive Ingredients
Ingredient Name	Strength
MINERAL OIL	90.00 mg in 250 mL
water	84.928 mg in 250 mL
PROPYLENE GLYCOL	17.50 mg in 250 mL
GLYCERIN	12.50 mg in 250 mL
GLYCERYL STEARATE SE	6.875 mg in 250 mL
ISOPROPYL MYRISTATE	6.25 mg in 250 mL
CETOSTEARYL ALCOHOL	3.75 mg in 250 mL
PETROLATUM	3.75 mg in 250 mL
POLYSORBATE 60	3.75 mg in 250 mL
PEG-100 STEARATE	3.125 mg in 250 mL
YELLOW WAX	3.00 mg in 250 mL
SORBITAN SESQUIOLEATE	3.00 mg in 250 mL
STEARIC ACID	2.50 mg in 250 mL
OLIVE OIL	2.00 mg in 250 mL
DIMETHICONE	1.25 mg in 250 mL
PHENOXYETHANOL	0.75 mg in 250 mL
PROPYLPARABEN	0.50 mg in 250 mL
METHYLPARABEN	0.50 mg in 250 mL
EDETATE DISODIUM	0.125 mg in 250 mL
TROLAMINE	0.125 mg in 250 mL
SODIUM DESOXYCHOLATE	0.030 mg in 250 mL
GINKGO BILOBA LEAF OIL	0.025 mg in 250 mL
SOYBEAN OIL	0.010 mg in 250 mL
HYDROGENATED SOYBEAN LECITHIN	0.005 mg in 250 mL
SODIUM OLEATE	0.001 mg in 250 mL
CARNITINE	0.00025 mg in 250 mL
EPIGALLOCATECHIN GALLATE	0.00025 mg in 250 mL
MECASERMIN	0.0000375 mg in 250 mL

Packaging
#	Item Code	Package Description
1	NDC:60709-107-02	1 TUBE in 1 CARTON
1	NDC:60709-107-01	250 mL in 1 TUBE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part343	11/15/2013

Labeler - YBK Investment, INC (010397213)

Registrant - YBK Investment, INC (010397213)

Establishment
Name	Address	ID/FEI	Operations
Caregen Co., Ltd.		689850365	manufacture(60709-107)

Revised: 12/2013

Document Id: f1811ea6-640d-40bf-ae08-05d9e9d476ad

Set id: 96e4d5fe-f459-41f7-b446-342c12880223

Version: 1

Effective Time: 20131211

YBK Investment, INC

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer